> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Corrects Regs on NADA Hearing Procedures
- URL: https://www.fdaweb.com/fda-corrects-regs-on-nada-hearing-procedures/
- Published: 2016-08-11T12:00:00.000Z
- Updated: 2026-09-14T21:23:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136484

*Federal Register* Final rule: FDA is making technical corrections to its regulations for hearing procedures for denial of approval or withdrawal of approval of new animal drug applications. FDA is revising Sec. 514.200 to make its language and terminology consistent with the language and terminology of the procedural regulations for hearings in Part 12\. The agency is changing the references to “administrative law judge” in current Sec. 514.200 to the term “presiding officer.” FDA is also updating the language in current Sec. 514.200 from “written appearance” to “objections and request for a hearing” since the latter terminology is used throughout Part 12\. Finally, FDA is updating the language in Sec. 514.200 on the contents of the objections and request for hearing and the contents of the Commissioner’s notice granting a hearing to match the language of Part 12 and to make clear what is required. All of these corrections are nonsubstantive, technical amendments designed to harmonize the language and terminology of Sec. 514.200\. To view this final rule, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-08-11/pdf/2016-18809.pdf?ref=fdaweb.com)